NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 36 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31 | -3.1% | 350 | 0.0% | 0.00% | – |
| Q2 2023 | $32 | -64.8% | 350 | 0.0% | 0.00% | – |
| Q1 2023 | $91 | +23.0% | 350 | 0.0% | 0.00% | – |
| Q4 2022 | $74 | – | 350 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 350 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 350 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 350 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 350 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 350 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 52,926 | $113,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 109,940 | $236,000 | 0.01% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $22,000 | 0.00% |
| Sowell Financial Services LLC | 11,190 | $24,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 101,949 | $219,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 32,822 | $71,000 | 0.00% |
| UBS Group AG | 816 | $2,000 | 0.00% |
| IFP Advisors, Inc | 50 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 6 | $0 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $2,000 | 0.00% |